Featured Research

from universities, journals, and other organizations

Going to the gym shouldn't be a workout for your eardrums

Date:
January 21, 2010
Source:
University of Alberta
Summary:
Listening to an iPod while working out feels like second nature to many people, but one researcher says we need to consider the volume levels in our earphones while working up a sweat.

Listening to an iPod while working out feels like second nature to many people, but University of Alberta researcher Bill Hodgetts says we need to consider the volume levels in our earphones while working up a sweat.

Hodgetts, assistant professor in the Department of Speech Pathology and Audiology at the Faculty of Rehabilitation Medicine, says his research has found that exercising in a gym often prompts people to turn up the volume to potentially unsafe levels for the ear.

The researcher found that the study participants, who were in a gym-like setting, listened at potentially dangerous levels while working out, likely due to the presence of background noise. But he says it isn't the listening level alone that's risky, it's how long a person listens at that level. What Hodgetts found is that almost half of his study participants listened for a length of time during exercise that put them at risk for hearing loss.

The good news? The solution is simple, he says: get better earphones, those that "seal" the ear canal, acting as an earplug and thus reducing background noise.

Hodgetts' mission is to get the message out that proper earphones will make a huge difference in auditory health while allowing people to enjoy music at a lower, and safer volume.

Hodgetts' research was recently published in the International Journal of Audiology.


Story Source:

The above story is based on materials provided by University of Alberta. Note: Materials may be edited for content and length.


Cite This Page:

University of Alberta. "Going to the gym shouldn't be a workout for your eardrums." ScienceDaily. ScienceDaily, 21 January 2010. <www.sciencedaily.com/releases/2010/01/100120131205.htm>.
University of Alberta. (2010, January 21). Going to the gym shouldn't be a workout for your eardrums. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/01/100120131205.htm
University of Alberta. "Going to the gym shouldn't be a workout for your eardrums." ScienceDaily. www.sciencedaily.com/releases/2010/01/100120131205.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins